Ignite Creation Date:
2025-12-24 @ 6:28 PM
Ignite Modification Date:
2026-05-19 @ 10:37 AM
Study NCT ID:
NCT04858568
Status:
COMPLETED
Last Update Posted:
2024-02-06
First Post:
2021-04-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immune Responses to COVID-19 Vaccination in Lymphoma Patients
Sponsor:
University Hospital Southampton NHS Foundation Trust
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Classical Hodgkin Lymphoma | View |
| None | Diffuse Large B Cell Lymphoma | View |
| None | Primary Mediastinal B Cell Lymphoma | View |
| None | High-grade B-cell Lymphoma | View |
| None | Burkitt Lymphoma | View |
| None | Follicular Lymphoma | View |
| None | Mantle Cell Lymphoma | View |
| None | Marginal Zone Lymphoma | View |
| None | Chronic Lymphocytic Leukemia | View |
| None | Small Lymphocytic Lymphoma | View |
| None | Lymphoplasmacytic Lymphoma | View |
| None | Nodular Lymphocyte Predominant Hodgkin Lymphoma | View |
| None | Peripheral T-cell Lymphoma | View |
Keywords: